Search

Author/Creator Li, L.

1. 127 AN APPROACH TO IDENTIFY EPISTATIC GENES INVOLVED IN THE DEVELOPMENT OF AUTISM SPECTRUM DISORDER IN PATIENTS WITH FRAGILE X SYNDROME. (1st January 2004)

Authors:
Nowicki, S. T.; Jacquemont, S.; Li, L.; Nguyen, D. V.; Gregg, J. P.; Hagerman, R. J.; Hagerman, P. J.; Institute, M. I.N.D.
Journal:
Journal of investigative medicine
Issue:
Volume 52(2004)Supplement 1
Page Start:
S101
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 171P Pharmacodynamic (PD) biomarker analysis from CheckMate (CM) 8KX: A multitumor study of a subcutaneous (SC) formulation of nivolumab (NIVO) monotherapy. (December 2022)

Authors:
Jackson, C.G.C.A.; Perumal, D.; Lugowska, I.; O'Donnell, A.; North, R.T.; Calvo Ferrandiz, P.A.; Latten-Jansen, L.M.; Sánchez, C.G.; Medina Rodríguez, L.M.; Santoro, A.; Li, L.; Sidik, K.; Tang, T.; Deutsch, J.S.; Taube, J.; Horak, C.; Ravimohan, S.; Lonardi, S.
Journal:
Immuno-oncology technology
Issue:
Volume 16(2022)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 1848 Phase II clinical trial of metronomic oral capecitabine therapy combined with aromatase inhibitors in postmenopausal metastatic and recurrent breast cancer resistant to first-line aromatase inhibitors. (September 2015)

Authors:
Jian-wei, L.; Xiao-qing, J.; Li, L.; Yu-jie, W.; Zhi-min, S.; Zhen-zhou, S.; Zhong-hua, W.; Xi-chun, H.; Guang-yu, L.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S281
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 2131 Efficacy and safety of nab-paclitaxel (nab-P) in patients (pts) with previously treated metastatic colorectal cancer (mCRC): The phase II COLO-001 trial. (September 2015)

Authors:
Ducreux, M.; Bennouna, J.; Adenis, A.; Conroy, T.; Lievre, A.; Portales, F.; McGovern, D.; Li, L.; Romano, A.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S376
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. 2870 Prospective evaluation of both plasma Epstein Barr Virus (EBV) DNA clearance and fludeoxyglucose-positron emission tomography (PET-CT) as a dual-endpoint in predicting early response and survival of patients undergoing chemotherapy (chemo) for advanced nasopharyngeal carcinoma (NPC) (NCT01365208). (September 2015)

Authors:
Ma, B.; Leung, S.F.; Hui, E.P.; King, A.D.; Wang, K.; Mo, F.; Li, L.; Loong, H.; Kam, M.; Chan, A.; Wong, S.C.C.; Chan, A.T.C.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S580
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. 305 Influencing sorafenib disposition by blocking hepatocellular sorafenib-glucuronide uptake with rifampin in mice and humans. (September 2015)

Authors:
Bins, S.; Van Doorn, L.; Gibson, A.; Hu, S.; Li, L.; Vasilyeva, A.; Hamberg, P.; Eskens, F.; De Bruijn, P.; Sparreboom, A.; Mathijssen, R.; Baker, S.
Journal:
European journal of cancer
Issue:
Volume 51(2015)Supplement 3
Page Start:
S56
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. 57 Crizotinib in clinical practice: the North East of England's experience. (January 2016)

Authors:
Hall, S.; Lambourne, B.; Aynsley, E.; Gardiner, J.; Greystoke, A.; Hughes, A.; Jones, C.; Leaning, D.; Li, L.; Mansy, T.; Margetts, J.; Mcdonald, F.; Mcmenemin, R.; Mulvenna, P.; Peedell, C.; Shakespeare, D.; Simmons, T.; Singhal, S.; Turnbull, H.
Journal:
Lung cancer
Issue:
Volume 91(2016)Supplement 1
Page Start:
S21
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗